However, stroke patients have a greater brain atrophy rate than normal controls (Brodtmann et al., 2020), and the correlation between CSF tau protein level and brain atrophy severity is still significant 1 year after stroke, suggesting stroke may enhance or trigger tau-linked neurodegeneration with loss of neurons (Ihle-Hansen et al., 2017). The gene discussed is MAPT; the disease is Stroke.